← Eichor
Study identifier: NCT06946498 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.

Condition: Suspected Malignant Lung Neoplasm · Pleural Effusion · Pleural Effusion, Malignant  ·  Sponsor: National and Kapodistrian University of Athens

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

Non randomized study with two groups. The study group includes patients with suspected malignant pleural effusion, in whom the investigation of pleural effusion begins directly with pleural biopsy by Local Anesthesia Thoracoscopy (LAT). The Control Group includes patients who come to the same hospital and are treated with the Standard of Care (SOC) strategies were used. Efficacy of LAT, Sensitivity, Hospitalization, time to diagnosis and general safety and comfort of the groups' subjects will be assessed.

This description comes directly from the study's public registry record.

Talk to the study team

Nektarios ANAGNOSTOPOULOS, Ass. professor  ·  +306946869480  ·  aris.anag@yahoo.gr

Michail Kon/nos Tsatsis, MD, MSc, PhDc  ·  +306979234105  ·  tsatsis.mihail@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sotiria General Hospital of Thoracic DiseasesAthens, Attica, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06946498